Nutra Pharma (OTCBB: NPHC) Chairman and Chief Executive Officer, Rik J Deitsch, Interviewed by CEOCFO.com
Click Here for Full Article:
Company Profile:
Nutra Pharma Corp. is a biopharmaceutical company specializing in the acquisition, licensing and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune and infectious diseases. Nutra Pharma Corp. through its subsidiaries carries out basic drug discovery research and clinical development and also seeks strategic licensing partnerships to reduce the risks associated with the drug development process. The Company's subsidiary, ReceptoPharm, Inc., is developing these technologies for the production of drugs for HIV and Multiple Sclerosis ("MS"). The Company's subsidiary, Designer Diagnostics, is engaged in the research and development of diagnostic test kits designed to be used for the rapid identification of infectious diseases such as Paratuberculosis (para-TB) and Mycobacterium avium-intracellulare (MAI). Nutra Pharma continues to identify and acquire intellectual property and companies in the biotechnology arena.
Kevin McKnight1-800-404-8982Undiscovered Equities, Inc.1515 S Federal Hwy, Ste 207Boca Raton, FL 33432www.undiscoveredequities.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment